Polymyxin B causes DNA damage in HK-2 cells and mice

[1]  M. Ouellette,et al.  Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. , 2017, The Lancet. Infectious diseases.

[2]  Prateek Shrivastava,et al.  World health organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics , 2018 .

[3]  D. Amor,et al.  Loss of RMI2 Increases Genome Instability and Causes a Bloom-Like Syndrome , 2016, PLoS genetics.

[4]  U. Surana,et al.  Condensin recruitment to chromatin is inhibited by Chk2 kinase in response to DNA damage , 2016, Cell cycle.

[5]  I. Hickson,et al.  PICH promotes mitotic chromosome segregation: Identification of a novel role in rDNA disjunction , 2016, Cell cycle.

[6]  Jinli Wang,et al.  p53 Mediates Colistin-Induced Autophagy and Apoptosis in PC-12 Cells , 2016, Antimicrobial Agents and Chemotherapy.

[7]  R. Nation,et al.  A Novel Chemical Biology Approach for Mapping of Polymyxin Lipopeptide Antibody Binding Epitopes. , 2016, ACS infectious diseases.

[8]  J. R. Paulson,et al.  Condensin I and II behaviour in interphase nuclei and cells undergoing premature chromosome condensation , 2016, Chromosome Research.

[9]  Shery Jacob,et al.  A simple practice guide for dose conversion between animals and human , 2016, Journal of basic and clinical pharmacy.

[10]  Fanfan Zhou,et al.  Human oligopeptide transporter 2 (PEPT2) mediates cellular uptake of polymyxins. , 2015, The Journal of antimicrobial chemotherapy.

[11]  D. Paterson,et al.  Dosing Guidance for Intravenous Colistin in Critically Ill Patients. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  J. Li,et al.  Cellular Uptake and Localization of Polymyxins in Renal Tubular Cells Using Rationally Designed Fluorescent Probes , 2015, Antimicrobial Agents and Chemotherapy.

[13]  J. Li,et al.  Antimicrobial Activity and Toxicity of the Major Lipopeptide Components of Polymyxin B and Colistin: Last-line Antibiotics against Multidrug-Resistant Gram-negative Bacteria. , 2015, ACS infectious diseases.

[14]  Jidong Yang,et al.  Detection of DNA utilizing a fluorescent reversible change of a biosensor based on the electron transfer from quantum dots to polymyxin B sulfate. , 2015, Journal of colloid and interface science.

[15]  Jinli Wang,et al.  Autophagy Regulates Colistin-Induced Apoptosis in PC-12 Cells , 2015, Antimicrobial Agents and Chemotherapy.

[16]  K. Rogers,et al.  Major Pathways of Polymyxin-Induced Apoptosis in Rat Kidney Proximal Tubular Cells , 2015, Antimicrobial Agents and Chemotherapy.

[17]  T. Velkov,et al.  Lycopene Attenuates Colistin-Induced Nephrotoxicity in Mice via Activation of the Nrf2/HO-1 Pathway , 2014, Antimicrobial Agents and Chemotherapy.

[18]  Carl Nathan,et al.  Antibiotic resistance--problems, progress, and prospects. , 2014, The New England journal of medicine.

[19]  Y. Liu,et al.  The origins and processing of ultra fine anaphase DNA bridges. , 2014, Current opinion in genetics & development.

[20]  Jichang Li,et al.  Colistin-Induced Nephrotoxicity in Mice Involves the Mitochondrial, Death Receptor, and Endoplasmic Reticulum Pathways , 2014, Antimicrobial Agents and Chemotherapy.

[21]  J. Li,et al.  Teaching ‘Old’ Polymyxins New Tricks: New-Generation Lipopeptides Targeting Gram-Negative ‘Superbugs’ , 2014, ACS chemical biology.

[22]  Douglas Ferguson,et al.  Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  I. Hickson,et al.  How unfinished business from S‐phase affects mitosis and beyond , 2013, The EMBO journal.

[24]  H. Yamaguchi,et al.  Megalin Contributes to Kidney Accumulation and Nephrotoxicity of Colistin , 2013, Antimicrobial Agents and Chemotherapy.

[25]  A. Schnittger,et al.  Cell cycle control across the eukaryotic kingdom. , 2013, Trends in cell biology.

[26]  Roger L. Nation,et al.  Polymyxin B Induces Apoptosis in Kidney Proximal Tubular Cells , 2013, Antimicrobial Agents and Chemotherapy.

[27]  Ronald N. Jones,et al.  10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  R. Nation,et al.  Pharmacology of polymyxins: new insights into an 'old' class of antibiotics. , 2013, Future microbiology.

[29]  C. Landersdorfer,et al.  Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  S. Halder,et al.  Role of p97/VCP (Cdc48) in genome stability , 2013, Front. Genet..

[31]  D. Calfee,et al.  Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy. , 2012, The Journal of infection.

[32]  M. Vaara,et al.  Novel polymyxin derivatives are less cytotoxic than polymyxin B to renal proximal tubular cells , 2012, Peptides.

[33]  A. Kumar.  Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System , 2012 .

[34]  D. Jabes.  The antibiotic R&D pipeline: an update. , 2011, Current opinion in microbiology.

[35]  Jian Li,et al.  Melatonin Attenuates Colistin-Induced Nephrotoxicity in Rats , 2011, Antimicrobial Agents and Chemotherapy.

[36]  Xiaoli Hu,et al.  Interaction of polymyxin B with ds-DNA, and determination of DNA or polymyxin B via resonance Rayleigh scattering and resonance non-linear scattering spectra , 2011 .

[37]  J. López-Novoa,et al.  New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. , 2011, Kidney international.

[38]  M. Fenech,et al.  Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. , 2011, Mutagenesis.

[39]  Neang S. Ly,et al.  Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing , 2010, Pharmacotherapy.

[40]  T. Pruett.  Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America , 2010 .

[41]  I. Hickson,et al.  Genomic instability and cancer: lessons from analysis of Bloom's syndrome. , 2009, Biochemical Society transactions.

[42]  J. Turnidge,et al.  Renal Disposition of Colistin in the Isolated Perfused Rat Kidney , 2009, Antimicrobial Agents and Chemotherapy.

[43]  Linda J. Kuo,et al.  γ-H 2 AX – A Novel Biomarker for DNA Double-strand Breaks , 2009 .

[44]  J. Li,et al.  Pharmacokinetics of intravenous polymyxin B in critically ill patients. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[45]  John Quale,et al.  Polymyxins Revisited , 2008, Clinical Microbiology Reviews.

[46]  Linda J. Kuo,et al.  γ-H2AX - A Novel Biomarker for DNA Double-strand Breaks , 2008 .

[47]  M. Falagas,et al.  Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? , 2007, International journal of antimicrobial agents.

[48]  A. Yoshimura,et al.  ER stress-induced apoptosis and caspase-12 activation occurs downstream of mitochondrial apoptosis involving Apaf-1 , 2006, Journal of Cell Science.

[49]  J. Turnidge,et al.  Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. , 2006, The Lancet. Infectious diseases.

[50]  Jiri Bartek,et al.  Cell-cycle checkpoints and cancer , 2004, Nature.

[51]  D. Livermore.  The need for new antibiotics. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[52]  J. Turnidge,et al.  Use of High-Performance Liquid Chromatography To Study the Pharmacokinetics of Colistin Sulfate in Rats following Intravenous Administration , 2003, Antimicrobial Agents and Chemotherapy.

[53]  M. Fenech.  Chromosomal biomarkers of genomic instability relevant to cancer. , 2002, Drug discovery today.

[54]  P. Szankasi,et al.  Cell-based assays for identification of novel double-strand break-inducing agents. , 2002, Journal of the National Cancer Institute.

[55]  J. Hoeijmakers,et al.  Chromosomal stability and the DNA double-stranded break connection , 2001, Nature Reviews Genetics.

[56]  W. Brownell,et al.  Essential role of BETA2/NeuroD1 in development of the vestibular and auditory systems. , 2000, Genes & development.

[57]  S. Elledge,et al.  Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. , 2000, Genes & development.

[58]  D. Graham,et al.  Effects of Large Doses of Colistin Sulphomethate Sodium on Renal Function , 1970, British medical journal.

[59]  E. Federman,et al.  Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. , 1970, Annals of internal medicine.

[60]  K. Liewendahl,et al.  THE THERAPEUTIC SUCCESS AND NEPHROTOXICITY OF COLISTIN IN ACUTE AND CHRONIC NEPHROPATHIES WITH IMPAIRED RENAL FUNCTION. , 2009, Acta medica Scandinavica.

[61]  R. Katz.  RENAL AND POSSIBLY HEPATIC TOXICITY FROM COLY-MYCIN. REPORT OF A CASE. , 1963, The Medical annals of the District of Columbia.